SNWV · CIK 0001417663 · operating
SANUWAVE Health operates as a medical device manufacturer specializing in regenerative medicine technologies based on acoustic energy platforms. The company develops and commercializes noninvasive ultrasound and shockwave systems designed to stimulate biological tissue repair and regeneration across musculoskeletal, vascular, and wound care applications. Its product portfolio consists of the UltraMist system, which uses non-thermal ultrasound transmitted through a fluid mist for non-contact wound treatment, and the PACE (Pulsed Acoustic Cellular Expression) line of devices that employ acoustic pressure shockwaves for targeted therapeutic delivery.
The PACE platform supports multiple branded applications, including dermaPACE for dermatological and wound care, Profile for general wound applications, and orthoPACE for orthopedic indications. These devices target both acute and chronic wound conditions as well as musculoskeletal disorders.
The company maintains a lean operational structure with 46 full-time employees and operates from its headquarters in Eden Prairie, Minnesota. SANUWAVE conducts business both domestically in the United States and internationally, though geographic revenue distribution is not publicly detailed. As a Nasdaq-listed entity incorporated in Nevada, the company has a market capitalization of approximately $0.2 billion.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-7.03 | $-7.03 | -23333.3% | |
| 2023 | $-0.03 | $-0.03 | -50.0% | |
| 2022 | $-0.02 | $-0.02 | +60.0% | |
| 2021 | $-0.05 | $-0.05 | +37.5% | |
| 2020 | $-0.08 | $-0.08 | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | $-0.30 | $-0.30 | +42.3% | |
| 2011 | $-0.52 | $-0.52 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-20 | 0001628280-25-014141 | SEC ↗ |
| 2023-12-31 | 2024-03-21 | 0001140361-24-014611 | SEC ↗ |
| 2022-12-31 | 2023-03-31 | 0001140361-23-015331 | SEC ↗ |
| 2021-12-31 | 2022-05-13 | 0001140361-22-019072 | SEC ↗ |
| 2020-12-31 | 2021-10-21 | 0001140361-21-035116 | SEC ↗ |
| 2019-12-31 | 2020-03-30 | 0001654954-20-003538 | SEC ↗ |
| 2018-12-31 | 2019-04-01 | 0001654954-19-003872 | SEC ↗ |
| 2017-12-31 | 2018-03-29 | 0001654954-18-003375 | SEC ↗ |
| 2016-12-31 | 2017-03-31 | 0001437749-17-005765 | SEC ↗ |
| 2015-12-31 | 2016-03-30 | 0001437749-16-028700 | SEC ↗ |
| 2014-12-31 | 2015-03-03 | 0001437749-15-003987 | SEC ↗ |
| 2013-12-31 | 2014-03-31 | 0001437749-14-005532 | SEC ↗ |
| 2012-12-31 | 2013-03-26 | 0001437749-13-003482 | SEC ↗ |
| 2011-12-31 | 2012-03-14 | 0001437749-12-002307 | SEC ↗ |
| 2010-12-31 | 2011-03-28 | 0000950123-11-029797 | SEC ↗ |
| 2009-12-31 | 2010-03-31 | 0000950123-10-030278 | SEC ↗ |
| 2008-12-31 | 2009-03-31 | 0001078782-09-000470 | SEC ↗ |
| 2007-12-31 | 2008-05-20 | 0001078782-08-000753 | SEC ↗ |